Systemic therapy of hepatocellular carcinoma on non-cirrhotic liver: a prospective spanish multicentre study
Latest Information Update: 14 Aug 2024
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Lenvatinib (Primary) ; Sorafenib (Primary) ; Antineoplastics
- Indications Liver cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 14 Aug 2024 New trial record